Dr. Kudrik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
166 Stoneridge Dr
Columbia, SC 29210Phone+1 803-461-3000Fax+1 803-461-4910
Summary
- President of S.C. Oncology Associates
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2000 - 2002
University of RochesterResidency, Internal Medicine, 1997 - 2000
Case Western Reserve University School of MedicineClass of 1997
Certifications & Licensure
SC State Medical License 2002 - 2025
NC State Medical License 1999 - 2002
NY State Medical License 1998 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Clinical Trials
- Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary Start of enrollment: 2009 Feb 01
- Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Start of enrollment: 2011 Jan 11
Publications & Presentations
PubMed
- 8 citationsPhase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC).John D. Hainsworth, David M. Waterhouse, Kent C. Shih, Ralph V. Boccia, Victor M. Priego
Lung Cancer. 2018-04-01 - 17 citationsTITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancerDenise A. Yardley, Edward Arrowsmith, Brooke R. Daniel, Janice F. Eakle, Adam Brufsky
Breast Cancer Research and Treatment. 2017-05-15 - 117 citationsA Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adeno...Al B. Benson, Zev A. Wainberg, J. Randolph Hecht, Dmitry Vyushkov, Hua Dong
The Oncologist. 2017-03-01
Press Mentions
Integra Connect to Present Key Clinical Research at the ASCO Quality Care SymposiumOctober 26th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
